(@dgormanj)

AoU Research Priorities Use Cases

What is the prevalence of hereditary hemochromatosis in the U.S. population?

Looking for the hereditary hemochromatosis gene (carriers or people who have this recessive disease) in DNA sequencing and blood tests. Testing ferritin, transferritin saturation, TIBC, and iron levels in patient blood labs; testing liver function in patient blood labs; testing chemical panel with glucose in patient blood labs; testing CBC in patient blood labs; testing lipid panel (cholesterol, triglycerides, HDL,... more »

Voting

3 votes
Ideate
(@dgormanj)

AoU Research Priorities Use Cases

What is the prevalence of hereditary hemochromatosis in the U.S. population?

Looking for the hereditary hemochromatosis gene (carriers or people who have this recessive disease) in DNA sequencing and blood tests. Testing ferritin, transferritin saturation, TIBC, and iron levels in patient blood labs; testing liver function in patient blood labs; testing chemical panel with glucose in patient blood labs; testing CBC in patient blood labs; testing lipid panel (cholesterol, triglycerides, HDL,... more »

Voting

3 votes
Ideate
(@sjogrens.syndrome.foundation)

AoU Research Priorities Use Cases

What are the pathogenic mechanisms leading to the development of blood cancers in autoimmune disease patients?

Patients with autoimmune diseases have been found to be at a higher risk of certain types of cancers, particularly hematologic cancers. A recent study found that patients with Sjögren's were eleven times more likely to develop a hematologic cancer compared to patients without Sjögren's. The purpose of this study is to identify the pathogenic mechanisms leading to the development of blood and other cancers in patients... more »

Voting

22 votes
Ideate
(@sjogrens.syndrome.foundation)

AoU Research Priorities Use Cases

What are the pathogenic mechanisms leading to the development of blood cancers in autoimmune disease patients?

Patients with autoimmune diseases have been found to be at a higher risk of certain types of cancers, particularly hematologic cancers. A recent study found that patients with Sjögren's were eleven times more likely to develop a hematologic cancer compared to patients without Sjögren's. The purpose of this study is to identify the pathogenic mechanisms leading to the development of blood and other cancers in patients... more »

Voting

22 votes
Ideate